Plus: The 'worst imaginable' brain tumor yields, in some young people, to CAR-T therapyNovember 15, 2024Check out STAT+Sponsored By Wikimedia Commons STAT+ | 'Worst imaginable' brain tumor yields, in some young people, to CAR-T therapy A CAR-T trial is one of several efforts that suggest there's hope of treating the "worst imaginable childhood brain tumor," known as DIPG. By Jason Mast STAT+ | Mass General doctor reveals cause of death of historic pig kidney transplant patient A Mass General doctor said that the recipient of a genetically engineered pig kidney who died last May had shown no signs of organ rejection. By Adam Piore — Boston Globe STAT+ | Vertex's upcoming sciatica trial readout is a high-stakes moment in its quest to quell pain The sciatica study results, expected shortly, will be crucial for Vertex, and for people wracked by chronic pain By Jonathan Wosen Matt Rourke/AP STAT+ | Trump's pick of RFK Jr. at HHS: The scientific community, and biopharma investors, respond Leaders throughout the biopharma world and scientific community struggled to process news that President-elect Donald Trump had tapped RFK Jr. to lead HHS. By Jonathan Wosen, Adam Feuerstein, Allison DeAngelis, Matthew Herper, and Ed Silverman AbbVie's stumble, Amgen's tumble, and more election fallout On STAT's podcast, hear about what happened with AbbVie's schizophrenia drug, Amgen's obesity drug and what might happen at the FDA, post-election. By Adam Feuerstein, Elaine Chen, and Allison DeAngelis STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman Matt Rourke/AP Opinion: FDA commissioner: We need action and higher-quality research on ultra-processed foods FDA Commissioner Robert M. Califf and colleagues call for a concerted effort to tackle diet-related disease. By Robert M. Califf, Haider J. Warraich, and Jim Jones More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2024, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments